Profile data is unavailable for this security.
About the company
Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.
- Revenue in USD (TTM)4.50bn
- Net income in USD-1.16bn
- Incorporated2000
- Employees10.59k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
- Websitehttps://www.illumina.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | 2.96bn | 427.20m | 11.34bn | 9.71k | 26.84 | 8.23 | 20.95 | 3.83 | 2.91 | 2.91 | 20.14 | 9.49 | 0.7542 | 1.64 | 6.15 | 305,398.20 | 10.85 | 8.38 | 14.99 | 11.40 | 51.17 | 49.85 | 14.39 | 11.39 | 0.9948 | 29.03 | 0.4756 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Revvity Inc | 2.75bn | 179.50m | 12.45bn | 11.50k | 69.94 | 1.58 | 20.36 | 4.53 | 1.44 | 5.50 | 22.03 | 63.79 | 0.1986 | 2.91 | 4.42 | 239,180.10 | 1.30 | 4.76 | 1.45 | 5.39 | 55.98 | 57.19 | 6.53 | 15.34 | 1.77 | 4.07 | 0.3313 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Avantor Inc | 6.97bn | 321.10m | 16.58bn | 14.50k | 51.59 | 3.14 | 22.92 | 2.38 | 0.4731 | 0.4731 | 10.28 | 7.76 | 0.5271 | 5.29 | 5.88 | 480,496.60 | 2.43 | 2.97 | 2.76 | 3.35 | 33.93 | 33.44 | 4.61 | 5.06 | 1.05 | 3.19 | 0.5132 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Waters Corp | 2.96bn | 642.23m | 17.75bn | 7.90k | 27.59 | 15.39 | 21.95 | 6.00 | 10.84 | 10.84 | 49.92 | 19.44 | 0.7477 | 2.46 | 4.15 | 374,229.90 | 16.24 | 19.77 | 20.28 | 25.29 | 59.57 | 58.45 | 21.72 | 23.38 | 1.57 | 9.94 | 0.6719 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Illumina Inc | 4.50bn | -1.16bn | 19.15bn | 10.59k | -- | 3.33 | -- | 4.25 | -7.34 | -7.34 | 28.51 | 36.13 | 0.4028 | 3.05 | 6.26 | 425,306.90 | -10.37 | -6.20 | -12.87 | -7.28 | 60.95 | 66.39 | -25.75 | -15.48 | 1.29 | -- | 0.2058 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Veralto Corp | 5.02bn | 839.00m | 22.52bn | 16.00k | 26.78 | 16.25 | 24.32 | 4.49 | 3.41 | 3.41 | 20.39 | 5.61 | -- | -- | -- | 313,812.50 | -- | -- | -- | -- | 57.78 | -- | 16.71 | -- | 1.40 | 38.60 | 0.6543 | -- | 3.10 | -- | -0.7101 | -- | -- | -- |
| Keysight Technologies Inc | 5.34bn | 969.00m | 25.27bn | 15.50k | 26.66 | 5.26 | 21.12 | 4.73 | 5.43 | 5.43 | 29.97 | 27.54 | 0.6102 | 1.95 | 6.18 | 358,523.50 | 11.07 | 11.69 | 13.92 | 14.21 | 64.81 | 62.09 | 18.14 | 17.75 | 1.44 | -- | 0.2739 | 0.00 | 0.8118 | 7.10 | -5.96 | 44.98 | 8.23 | -- |
| Mettler-Toledo International Inc | 3.79bn | 788.78m | 25.65bn | 16.00k | 33.42 | -- | 28.19 | 6.77 | 35.89 | 35.89 | 172.38 | -6.97 | 1.11 | 3.74 | 5.52 | 236,769.30 | 23.04 | 23.32 | 34.91 | 34.02 | 59.16 | 58.58 | 20.82 | 20.51 | 0.7149 | 14.01 | 1.08 | 0.00 | -3.35 | 5.23 | -9.60 | 8.85 | -5.90 | -- |
| Fortive Corp | 6.07bn | 865.80m | 28.24bn | 18.00k | 33.00 | 2.73 | 21.35 | 4.66 | 2.44 | 2.44 | 17.06 | 29.42 | 0.3698 | 4.60 | 5.98 | 336,961.10 | 5.28 | 4.90 | 6.12 | 6.00 | 59.26 | 57.15 | 14.27 | 15.01 | 1.75 | 9.65 | 0.261 | 12.88 | 4.11 | 9.80 | 14.65 | 14.69 | -0.8146 | 0.7043 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 17.50m | 11.02% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 9.06m | 5.70% |
| Edgewood Management LLCas of 31 Dec 2023 | 6.88m | 4.33% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 6.72m | 4.23% |
| Baillie Gifford & Co.as of 31 Dec 2023 | 5.28m | 3.32% |
| Loomis, Sayles & Co. LPas of 31 Dec 2023 | 4.42m | 2.79% |
| Janus Henderson Investors US LLCas of 31 Dec 2023 | 4.38m | 2.75% |
| Geode Capital Management LLCas of 31 Dec 2023 | 3.63m | 2.29% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 3.24m | 2.04% |
| AllianceBernstein LPas of 31 Dec 2023 | 2.68m | 1.69% |
